Mohamed Belhocine's Profile

Role	Title	Level	Year	L/R
🐜	H3K4 tri‐methylation provides an epigenetic signature of active enhancers 10 auth. Aleksandra Pękowska, T. Benoukraf, Joaquin Zacarías-Cabeza, Mohamed Belhocine, Frederic Koch, H. Holota, ... J. Imbert, J. Andrau, P. Ferrier, S. Spicuglia	8	2011	8 🐜
🐜	Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study. 20 auth. Jonathan Bond, C. Graux, L. Lhermitte, D. Lara, T. Cluzeau, T. Leguay, A. Cieslak, A. Trinquand, C. Pastoret, Mohamed Belhocine, ... S. Spicuglia, V. Lheritier, S. Leprêtre, X. Thomas, F. Huguet, N. Ifrah, H. Dombret, E. Macintyre, N. Boissel, V. Asnafi	7	2017	7 🐜
🐜	Divergent transcription is associated with promoters of transcriptional regulators 19 auth. C. Lepoivre, Mohamed Belhocine, A. Bergon, A. Griffon, Miriam Yammine, Laurent Vanhille, Joaquin Zacarías-Cabeza, Marc Garibal, Frederic Koch, M. Maqbool, ... Romain Fenouil, B. Loriod, H. Holota, M. Gut, I. Gut, J. Imbert, J. Andrau, D. Puthier, S. Spicuglia	6	2013	6 🐜
🐬	[Functions of lncRNA in development and diseases]. Evelyne Mathieu, Mohamed Belhocine, Lan T M Dao, D. Puthier, S. Spicuglia	6	2014	6 🐬
🐜	Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia. 15 auth. Laurent Renou, P. Boelle, C. Deswarte, S. Spicuglia, Aissa Benyoucef, J. Calvo, B. Uzan, Mohamed Belhocine, A. Cieslak, J. Landman-Parker, ... A. Baruchel, V. Asnafi, F. Pflumio, P. Ballerini, I. Naguibneva	5	2017	5 🐜
🐜	Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia. 22 auth. A. Trinquand, Nuno R. dos Santos, C. Tran Quang, F. Rocchetti, Benedetta Zaniboni, Mohamed Belhocine, Cindy da Costa de Jesus, L. Lhermitte, M. Tesio, M. Dussiot, ... F. Cosset, E. Verhoeyen, F. Pflumio, N. Ifrah, H. Dombret, S. Spicuglia, L. Chatenoud, D. Gross, O. Hermine, E. Macintyre, J. Ghysdael, V. Asnafi	4	2016	4 🐜
🐜	Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL 20 auth. A. Touzart, E. Lengliné, M. Latiri, Mohamed Belhocine, Charlotte Smith, X. Thomas, S. Spicuglia, D. Puthier, F. Pflumio, T. Leguay, ... C. Graux, Y. Chalandon, F. Huguet, S. Leprêtre, N. Ifrah, H. Dombret, E. Macintyre, M. Hunault, N. Boissel, V. Asnafi	4	2019	4 🐜
🐜	Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation 20 auth. A. Cieslak, Guillaume Charbonnier, M. Tesio, Evelyne Mathieu, Mohamed Belhocine, A. Touzart, Charlotte Smith, G. Hypolite, G. Andrieu, J. Martens, ... E. Janssen-Megens, M. Gut, I. Gut, N. Boissel, A. Petit, D. Puthier, E. Macintyre, H. Stunnenberg, S. Spicuglia, V. Asnafi	4	2020	4 🐜
🐜	TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome 24 auth. P. Villarese, P. Villarese, C. Lours, C. Lours, A. Trinquand, A. Trinquand, S. L. Noir, Mohamed Belhocine, Mohamed Belhocine, Mohamed Belhocine, ... L. Lhermitte, L. Lhermitte, A. Cieslak, M. Tesio, Audrey Petit, M. Lelorch, S. Spicuglia, N. Ifrah, H. Dombret, A. Langerak, N. Boissel, Elizabeth Macintyre, V. Asnafi, V. Asnafi	4	2018	4 🐜